5 Oct 2026, 08:23
Securities Administration—
TLXTELIX PHARMACEUTICALS LIMITED
Announcement history available from 1 August 2025
Fromto
5 Oct 2026, 08:22
Securities Administration—
5 Oct 2026, 08:22
Securities Administration—
30 Sept 2026, 08:20
Company UpdateMS
25 Sept 2026, 18:06
Substantial Holders—
25 Sept 2026, 15:31
Director Interests—
25 Sept 2026, 15:17
Securities Administration—
22 Sept 2026, 08:24
Securities Administration—
21 Sept 2026, 08:38
Company UpdateMS
21 Sept 2026, 08:37
Mergers & AcquisitionsMS
14 Sept 2026, 16:41
Securities Administration—
14 Sept 2026, 08:21
Company UpdateMS
2 Sept 2026, 08:16
Company Update—
1 Sept 2026, 08:18
Company Administration—
20 Aug 2026, 08:42
Financial ResultsMS
20 Aug 2026, 08:41
Financial ResultsMS
20 Aug 2026, 08:40
Financial ResultsMS
31 July 2026, 08:30
Presentations—
24 July 2026, 08:21
Substantial Holders—
21 July 2026, 08:26
Company UpdateMS
10 July 2026, 08:24
Securities Administration—
10 July 2026, 08:24
Securities Administration—
10 July 2026, 08:24
Securities Administration—
8 July 2026, 17:49
Substantial Holders—
3 July 2026, 13:36
Substantial Holders—
2 July 2026, 10:07
Company UpdateMS
1 July 2026, 12:38
Substantial Holders—
1 July 2026, 08:17
Substantial Holders—
30 June 2026, 17:24
Substantial Holders—
25 June 2026, 08:16
Substantial Holders—
23 June 2026, 17:32
Substantial Holders—
17 June 2026, 08:24
Director Interests—
9 June 2026, 08:13
Substantial Holders—
1 June 2026, 15:26
Securities Administration—
1 June 2026, 15:20
Director Interests—
1 June 2026, 15:16
Director Interests—
1 June 2026, 15:15
Director Interests—
1 June 2026, 15:12
Director Interests—
1 June 2026, 15:11
Director Interests—
26 May 2026, 16:50
Substantial Holders—
21 May 2026, 13:00
Meetings & Governance—
21 May 2026, 09:39
Presentations—
21 May 2026, 09:38
Letters & Addresses—
14 May 2026, 09:27
Director Interests—
14 May 2026, 09:21
Director Interests—
14 May 2026, 09:20
Director Interests—
11 May 2026, 18:01
Substantial Holders—
8 May 2026, 10:14
Securities Administration—
8 May 2026, 09:10
Securities Administration—
8 May 2026, 09:04
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:23 | Notification of cessation of securities - TLX | Securities Administration | — | 06027 | |
| 5 Oct 2026, 08:22 | Notification regarding unquoted securities - TLX | Securities Administration | — | 06021 | |
| 5 Oct 2026, 08:22 | Application for quotation of securities - TLX | Securities Administration | — | 06020 | |
| 30 Sept 2026, 08:20 | FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging | Company Update | MS | 11001 | |
| 25 Sept 2026, 18:06 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 Sept 2026, 15:31 | Appendix 3Y Change in Director Interest-D Gill | Director Interests | — | 02009 | |
| 25 Sept 2026, 15:17 | Application for quotation of securities - TLX | Securities Administration | — | 06020 | |
| 22 Sept 2026, 08:24 | Grant of waivers of Listing Rule 7.3.4 | Securities Administration | — | 12016 | |
| 21 Sept 2026, 08:38 | Telix and ITM Join Forces to Create Radiopharma Powerhouse | Company Update | MS | 03026, 11001 | |
| 21 Sept 2026, 08:37 | Telix and ITM Join Forces to Create Radiopharma Powerhouse | Mergers & Acquisitions | MS | 07001, 14014 | |
| 14 Sept 2026, 16:41 | Application for quotation of securities - TLX | Securities Administration | — | 06020 | |
| 14 Sept 2026, 08:21 | FDA Approves Telix Brain Cancer Imaging Drug Pixclara | Company Update | MS | 11001 | |
| 2 Sept 2026, 08:16 | Telix Completes Enrollment in Phase 3 BiPASS Study | Company Update | — | 11001 | |
| 1 Sept 2026, 08:18 | Telix Appoints David Gill as Chair | Company Administration | — | 12017 | |
| 20 Aug 2026, 08:42 | Telix HY26 Results Presentation | Financial Results | MS | 03004, 03026 | |
| 20 Aug 2026, 08:41 | Telix HY26 Results Announcement | Financial Results | MS | 03004, 14014 | |
| 20 Aug 2026, 08:40 | Telix HY26 Appendix 4D and Interim Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 31 July 2026, 08:30 | Telix H1 2026 Results - Investor Webcast Notification | Presentations | — | 03027, 14014 | |
| 24 July 2026, 08:21 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 21 July 2026, 08:26 | Q2 2026 Revenue US$247M Strong Momentum Pipeline Progress | Company Update | MS | 03014, 11001 | |
| 10 July 2026, 08:24 | Notification of cessation of securities - TLX | Securities Administration | — | 06027 | |
| 10 July 2026, 08:24 | Notification regarding unquoted securities - TLX | Securities Administration | — | 06021 | |
| 10 July 2026, 08:24 | Application for quotation of securities - TLX | Securities Administration | — | 06020 | |
| 8 July 2026, 17:49 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 3 July 2026, 13:36 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 2 July 2026, 10:07 | FDA Alignment to Advance ProstACT Global Phase 3 Trial | Company Update | MS | 11001 | |
| 1 July 2026, 12:38 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 1 July 2026, 08:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 30 June 2026, 17:24 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 25 June 2026, 08:16 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 23 June 2026, 17:32 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 17 June 2026, 08:24 | Appendix 3Y Change in Director Interest D Gill | Director Interests | — | 02009 | |
| 9 June 2026, 08:13 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 1 June 2026, 15:26 | Notification regarding unquoted securities - TLX | Securities Administration | — | 06021 | |
| 1 June 2026, 15:20 | Appendix 3Y Change in Director Interest - C Behrenbruch | Director Interests | — | 02009 | |
| 1 June 2026, 15:16 | Appendix 3Y Change in Director Interest - M McDonald | Director Interests | — | 02009 | |
| 1 June 2026, 15:15 | Appendix 3Y Change in Director Interest - W Jellison | Director Interests | — | 02009 | |
| 1 June 2026, 15:12 | Appendix 3Y Change in Director Interest - Maria Rivas | Director Interests | — | 02009 | |
| 1 June 2026, 15:11 | Appendix 3Y Change in Director Interest - David Gill | Director Interests | — | 02009 | |
| 26 May 2026, 16:50 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 21 May 2026, 13:00 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 21 May 2026, 09:39 | Telix Annual General Meeting Presentation | Presentations | — | 03026, 15002 | |
| 21 May 2026, 09:38 | Telix Annual General Meeting Chairman and CEO Addresses | Letters & Addresses | — | 15002 | |
| 14 May 2026, 09:27 | App 3X Initial Director Interests - W Jellison | Director Interests | — | 02008 | |
| 14 May 2026, 09:21 | App 3X Initial Director Interests - M Rivas | Director Interests | — | 02008 | |
| 14 May 2026, 09:20 | App 3X Initial Director Interests - D Gill | Director Interests | — | 02008 | |
| 11 May 2026, 18:01 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 May 2026, 10:14 | Cleansing Notice | Securities Administration | — | 06018 | |
| 8 May 2026, 09:10 | Application for quotation of securities - TLX | Securities Administration | — | 06020 | |
| 8 May 2026, 09:04 | Notification regarding unquoted securities - TLX | Securities Administration | — | 06021 |
1–50 of 143
1 / 3